ImmuCell Corporation Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
ImmuCell Corporation (ICCC) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 288.26 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-03-30
- ImmuCell Corporation share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 80.28K shares.
- ImmuCell Corporation share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2021-12-31 was 2.00K shares.
- ImmuCell Corporation share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2021-09-30 was 12.00K shares.
- ImmuCell Corporation share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 288.26K shares.
- ImmuCell Corporation share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 210.50K shares, a 144.77% increase from fiscal 2021.
- ImmuCell Corporation share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 86.00K shares.
- ImmuCell Corporation share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2017 was 141.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2025-12-31 | 80.28K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 288.26K shares 10-K · filed 2026-03-30 | ||
| 2025-09-30 | 207.98K shares 10-Q · filed 2025-11-13 | |||
| 2022-12-31 | 210.50K shares 10-K · filed 2024-04-01 | |||
| 2021-12-31 | 2.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | 14.00K shares derived: sum of 2 quarters · filed 2022-03-30 | 86.00K shares 10-K · filed 2022-03-30 | |
| 2021-09-30 | 12.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | 84.00K shares 10-Q · filed 2021-11-15 | ||
| 2021-06-30 | 72.00K shares 10-Q · filed 2021-08-12 | |||
| 2017-12-31 | 141.00K shares 10-K · filed 2018-03-29 | |||
| 2014-12-31 | 25.00K shares 10-K · filed 2015-03-26 | |||
| 2013-12-31 | 26.00K shares 10-K · filed 2015-03-26 | |||
| 2012-12-31 | 2.00K shares 10-K · filed 2015-03-26 | |||
| 2011-12-31 | 25.00K shares 10-K · filed 2014-03-26 | |||
| 2010-12-31 | 45.50K shares 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |